The multinational  market for brain cancer was valued at $500 million in 2012 and is expect to reach $1.1 billion by 2017, at a CAGR of 12.5%. Considerations like increased scope of neurological & immunological studies, clinical trials; rise in awareness for health & government and institution funds for research have exceedingly furnished for the ascending claim

http://neurooncology.conferenceseries.com/for the neuro oncologists, neurologists market.